Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome

Human Reproduction

Volumn 15, Issue 4, 2000, Pages 785-789

  Cibula, D ^a,b   Cifkova R ^a   Fanta, M ^b   Poledne, R ^b   Zivny, J ^a   Skibova J ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Coronary artery disease; Late risks; NIDDM; PCOS

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; RISK ASSESSMENT; RISK FACTOR; SMOKING;

FALLOPIA;

EID: 0343528010     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.4.785     Document Type: Article

References (26)

1. Atiomo, W.U., Bates, S.A., Condon, J.E. et al. (1998) The plasminogen activator system in women with polycystic ovary syndrome. Fertil. Steril., 69, 236-241.
2. Conway, O.S. and Jacobs, H.S. (1993) Clinical implications of hyperinsulinaemia in women. Clin. EndocrinoL, 39, 623-632.
3. Dahlgren, E., Johansson, S., Lindstedt, G. et al. (1992) Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long term follow-up focusing on natural history and circulating hormones. Fertil. Steril., 57, 505-513.
4. Dahlgren, E., Janson, P.O., Johansson, S. et al. (1994) Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil. Steril., 61, 455-460.
5. Dunaif, A. and Finegood, D.T. (1996) Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J. Clin. EndocrinoL Metab., 81, 942-947.
6. Dunaif, A., Graf, M., Mandeli, J. et al. (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J. Clin. EndocrinoL Metab., 65, 499-507.
7. Ehrmann, D.A. (1997) Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus. Baillière's Clin. Obstet. CynecoL, 11, 335-346.
8. Ehrman, D.A., Stuns, J., Byme, M.M. et al. (1995) Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin dependent diabetes mellitus. J. Clin. Invest., 96, 520-527.
9. Friedewald, W.T., Levy, R.I. and Frederickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin. Client., 18, 499-502.
10. Guzick, D.S., Talbott, E.G., Sutton-Tyrrell, K. et al. (1996) Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am. J. Obstet. GynecoL, 174, 1224-1232.
11. Harris, M.I., Hadden, W.C. and Knowler, W.C. (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in a US population aged 20-74 yr. Diabetes, 36, 523-534.
12. Holte, J., Bergh, T., Beme, Ch. et al. (1994a) Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometrie, endocrine and metabolic variables. Clin. EndocrinoL, 41, 463-471.
13. Holte, J., Bergh, T., Berne, C. et al. (1994b) Enhanced early insulin response in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J. Clin. EndocrinoL Metab., 78, 1052-1058.
14. Holte, J., Gennnarelli, G., Berne, C. et al. (1996) Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state? Hum. Reprod., 11, 23-28.
15. Lapidus, L., Bengtsson, C., Larsson, B. et al. (1984) Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br. Med. J., 289, 1257-1261.
16. Rajkhowa, Z., Neary, R.H., Kumptala, P. et al. (1997) Altered composition of high density lipoproteins in women with the polycystic ovary syndrome. J. Clin. EndocrinoL Metab., 82, 3389-3394.
17. Robinson, S., Henderson, A.D., Gelding, S.V. et al. (1996) Dyslipidemia is associated with insulin resistance in women with polycystic ovaries. Clin. EndocrinoL, 44, 277-284.
18. Sampson, M., Kong, Ch., Patel, A. et al. (1996) Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clin. EndocrinoL, 45, 623-629.
19. Sans, S., Kesteloot, H. and Kromhout, D. (1997) The burden of cardiovascular diseases mortality in Europe. Eur. Heart J., 18, 1231-1248.
20. Talbott, E., Guzick, D., Clerici, A. et al. (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler. Thromb. Vase. BioL, 15, 821-826.
21. Talbott, E., Clerici, A., Berga, S.L. et al. (1998) Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J. Clin. EpidemloL, 51, 415-422.
22. White, H.D., Birdsall, M.A. and Farquhar, CM. (1994) Association of polycystic ovaries with coronary artery disease (Abstract 686). Circulation, 90, 686.
23. Wild, R.A. and Bartholomew, M.J. (1988) The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome. Am. J. Obstet. Gynecol., 159, 423-427.
24. Wild, R.A., Painter, P.C., Coulson, P.B. et al. (1985) Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 61, 946-951.
25. Wild, R.A., Grubb, B., Hartz, A. et al. (1990) Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil. Steril., 54,255-259.
26. Yen, S.S.C. (1986) Chronic anovulation caused by peripheral endocrine disorders. In Yen, S.S.C. and Jaffe, R. (eds), Reproductive Endocrinology. Physiology, Pathophysiology and Clinical Management, 2nd edition. Saunders, Philadelphia, pp. 441-499.